In fact, some malignancies, such as non-small-cell lung, breast, prostate, and colorectal cancer, exhibit an abnormal activation of PI3K/AKT/mTOR signaling (Jiang et al., 2020; Yu et al., 2022). This evidence concerns the gene AKT1 and colorectal cancer.